SanBio Company Limited
SNBIF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $15 | $25 | $132 |
| Gross Profit | $0 | -$15 | -$25 | -$132 |
| % Margin | – | – | – | – |
| R&D Expenses | $2,357 | $2,850 | $6,118 | $4,955 |
| G&A Expenses | $0 | $0 | $1,781 | $1,665 |
| SG&A Expenses | $1,159 | $1,676 | $1,781 | $1,665 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,516 | $4,525 | $7,899 | $6,621 |
| Operating Income | -$3,516 | -$4,540 | -$7,899 | -$6,621 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $507 | $1,998 | $3,202 | $2,060 |
| Pre-Tax Income | -$3,009 | -$2,542 | -$4,697 | -$4,560 |
| Tax Expense | $127 | $102 | $862 | $117 |
| Net Income | -$2,882 | -$2,644 | -$5,560 | -$4,678 |
| % Margin | – | – | – | – |
| EPS | -41.85 | -40.48 | -95.99 | -90.33 |
| % Growth | -3.4% | 57.8% | -6.3% | – |
| EPS Diluted | -41.85 | -40.48 | -95.99 | -90.33 |
| Weighted Avg Shares Out | 69 | 65 | 58 | 52 |
| Weighted Avg Shares Out Dil | 69 | 65 | 58 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2 | $4 | $2 |
| Interest Expense | $6 | $26 | $25 | $45 |
| Depreciation & Amortization | $9 | $14 | $25 | $132 |
| EBITDA | -$3,507 | -$4,525 | -$4,649 | -$4,383 |
| % Margin | – | – | – | – |